Related Experiment Video

Updated: Aug 1, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.9K

LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential

Xiaoling Xu1, Huihui Li2, Mingying Xie1

  • 1Key Laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.

Critical Reviews in Oncology/Hematology
|April 28, 2023
PubMed

Insights

Malignant pleural mesothelioma (MPM) is a deadly cancer with poor survival rates. This review highlights long non-coding RNAs (lncRNAs) as potential therapeutic targets for developing new MPM treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant pleural mesothelioma (MPM) is an aggressive cancer with a poor prognosis, necessitating novel therapeutic strategies.
  • Current 5-year survival rates for MPM are below 10%, underscoring the urgent need for innovative treatment targets.
  • Long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and show potential in MPM.

Purpose of the Study:

  • To provide a comprehensive overview of the roles of lncRNAs in malignant pleural mesothelioma.
  • To explore the molecular underpinnings of MPM and their connection to lncRNAs.
  • To discuss the potential of lncRNAs as therapeutic targets for MPM treatment.

Main Methods:

  • Literature review of recent advances in MPM research.
  • Analysis of the molecular basis of MPM.
  • Investigation of lncRNA functions and dysregulation in MPM.

Main Results:

  • lncRNAs play significant roles in the molecular mechanisms of MPM development and progression.
  • Specific MPM-related lncRNAs have been identified with potential as biomarkers and therapeutic targets.
  • Understanding the interplay between molecular pathways and lncRNAs is crucial for MPM treatment.

Conclusions:

  • lncRNAs represent a promising class of therapeutic targets for malignant pleural mesothelioma.
  • Further research into MPM-associated lncRNAs could lead to the development of novel diagnostic and therapeutic approaches.
  • Targeting lncRNAs offers a potential avenue to improve outcomes for MPM patients.
Keywords:
Long non-coding RNAMalignant pleural mesotheliomaTherapeutic target

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.9K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
261
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K